Some argue that Norway must prioritize areas where we already have a competitive advantage, while others see an overarching strategy as the key to unlocking the full potential of our life science sector.

The question is no longer whether we need a strategy, but rather how quickly we can implement one to ensure Norway remains competitive in a rapidly evolving global landscape.

The case for a national life science strategy

Life sciences represent a key driver of economic growth and innovation worldwide. Across Europe, nations are doubling down on their life science industries with targeted policies, funding mechanisms, and long-term strategies. Norway, despite its strong research environment and growing industrial capabilities, risks falling behind if we do not align our efforts under a unified national framework.

Norway, despite its strong research environment and growing industrial capabilities, risks falling behind if we do not align our efforts under a unified national framework.

A well-crafted national life science strategy would:

  • Enhance coordination across academia, industry, and public institutions to bridge gaps in the innovation ecosystem.
  • Ensure long-term commitment to funding and infrastructure, reducing dependency on fragmented, short-term initiatives.
  • Strengthen Norway’s global competitiveness, enabling us to attract investments and talent in an industry where other nations are moving ahead.
  • Facilitate industrial scaling to transition Norway’s health and bio-industrial sectors from strong research foundations to viable commercial production.

Progress and the path forward – a call to action?

Norway has already taken an important step with the roadmap for the health industry (“Veikart for helsenæringen”), which provides a foundation for growth. However, the government has yet to commit to a dedicated life science strategy to build upon this progress.

While some policymakers acknowledge its potential benefits, others remain skeptical about its necessity.

However, our neighbors in Sweden and Denmark have successfully leveraged national strategies to accelerate growth and international positioning. Without a clear vision, Norway risks remaining a producer of great ideas that other countries commercialize.

Following Europe’s lead – why Norway must act now

The European Union’s new Competitiveness Compass places life sciences among the critical industries of the future. The Nordic region has the potential to lead within this space, but it requires Norway to step up.

If we do not act now, we risk losing talent, investments, and innovative breakthroughs to countries with more predictable and supportive frameworks. On the other hand, a national strategy can create a more attractive business environment, where Norwegian companies and researchers thrive, contributing to export growth and job creation.

Moving forward – a call for collective action

Industry, academia, and policymakers must come together to shape a strategic roadmap. This is not just about government action but about creating an ecosystem where all stakeholders have a role in defining the future of Norwegian life sciences. We must learn from successful models abroad while tailoring a strategy that leverages Norway’s unique strengths.

The window for debate is closing; now is the time to act. A national life science strategy is not a luxury – it is a necessity for securing Norway’s position in the global life science economy. Let’s not allow this opportunity to pass us by.

About the author

Delphine Costa is the CEO of The Life Science Cluster. The Life Science Cluster is working to unleash the potential of Norway’s life sciences sectors, bringing sustainable solutions to society and creating more jobs.